These Gene Therapy Stocks Are Spiking — Here's Why [Investor's Business Daily]
Sangamo Therapeutics, Inc. (SGMO)
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.sangamo.com
Company Research
Source: Investors Business Daily
Related news Shares of gene therapy companies Sangamo Therapeutics ( SGMO ) and Sarepta Therapeutics ( SRPT ) popped Thursday on bullish expectations for their respective hemophilia A and Duchenne muscular dystrophy treatments. In midday trading on the stock market today , Sangamo stock jumped 12% in high volume , near 15.50, and Sarepta stock leapt 9.1%, near 132. Meanwhile, shares of the broader biotech group rose 0.7%. Late Wednesday, Sangamo and partner Pfizer ( PFE ) unveiled data from a test of a gene therapy to treat hemophilia A . The field is ripe with contenders including Spark Therapeutics ( ONCE ) and BioMarin Pharmaceutical ( BMRN ). Sangamo and Pfizer plan to test up to 20 patients with severe hemophilia A. To date, five patients have received treatment at three different dose levels. So far, patients have tolerated the gene therapy with no treatment-related side effects. The fifth patient in the study was treated in June. Since then, that patient has experienced an impr
Show less
Read more
Impact Snapshot
Event Time:
SGMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGMO alerts
High impacting Sangamo Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SGMO
News
- What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today [Yahoo! Finance]Yahoo! Finance
- Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct OfferingBusiness Wire
- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, up previously from $3.00.MarketBeat
- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.MarketBeat
SGMO
Earnings
- 3/13/24 - Miss
SGMO
Sec Filings
- 3/25/24 - Form 8-K
- 3/25/24 - Form 424B5
- 3/13/24 - Form 8-K
- SGMO's page on the SEC website